Section 206 of the Food Allergen Labeling and Consumer Protection Act of 2004, Title II of Pub.L. 108–282, 118 "United States Statutes at Large" 891, enacted August 2, 2004
Cunningham-Rundles C (September 2001). «Physiology of IgA and IgA deficiency». J. Clin. Immunol.21 (5): 303–9. doi:10.1023/A:1012241117984. PMID11720003.
Karell K, Louka AS, Moodie SJ, et al. (2003). «HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease». Hum. Immunol.64 (4): 469–77. doi:10.1016/S0198-8859(03)00027-2. PMID12651074.
Michalski J, McCombs C, Arai T, Elston R, Cao T, McCarthy C, Stevens F (1996). «HLA-DR, DQ genotypes of celiac disease patients and healthy subjects from the West of Ireland». Tissue Antigens47 (2): 127–33. doi:10.1111/j.1399-0039.1996.tb02525.x. PMID8851726.
Kaur G, Sarkar N, Bhatnagar S, et al. (2002). «Pediatric celiac disease in India is associated with multiple DR3-DQ2 haplotypes». Hum. Immunol.63 (8): 677–82. doi:10.1016/S0198-8859(02)00413-5. PMID12121676.
Layrisse Z, Guedez Y, Domínguez E, Paz N, Montagnani S, Matos M, Herrera F, Ogando V, Balbas O, Rodríguez-Larralde A (2001). «Extended HLA haplotypes in a Carib Amerindian population: the Yucpa of the Perija Range». Hum Immunol62 (9): 992–1000. doi:10.1016/S0198-8859(01)00297-X. PMID11543901.
Zhernakova A et al (2010). «Evolutionary and Functional Analysis of Celiac Risk Loci Reveals SH2B3 as a Protective Factor against Bacterial Infection». The American Journal of Human Genetics86 (6): 970. doi:10.1016/j.ajhg.2010.05.004.
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken E, Schuppan D (1997). «Identification of tissue transglutaminase as the autoantigen of celiac disease». Nat Med3 (7): 797–801. doi:10.1038/nm0797-797. PMID9212111.
Fleckenstein B, Molberg 0, Qiao SW, Schmid DG, Mulbe E von der, Elgstoen K, Jung G and Soflid ML. (2002). «Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process». J Biol Chem277 (37): 34109–34116. doi:10.1074/jbc.M204521200. PMID12093810.
Koning, F.; Schuppan, D.; Cerf-Bensussan, N.; Sollid, M. (June 2005). «"Pathomechanisms in celiac disease"». Best practice & research. Clinical gastroenterology 19. 3, σελ. 373–387. doi:10.1016/j.bpg.2005.02.003. ISSN1521-6918. PMID15925843.
Mowat AM. (2003). «Coeliac disease – a meeting point for genetics, immunology, and protein chemistry». Lancet361 (9365): 1290–1292. doi:10.1016/S0140-6736(03)12989-3. PMID12699968.
Londei M, Ciacci C, Ricciardelli I, Vacca L, Quaratino S, and Maiuri L. (2005). «Gliadin as a stimulator of innate responses in celiac disease». Mol Immunol42 (8): 913–918. doi:10.1016/j.molimm.2004.12.005. PMID15829281.
Salim A, Phillips A, Farthing M (1990). «Pathogenesis of gut virus infection». Baillieres Clin Gastroenterol4 (3): 593–607. doi:10.1016/0950-3528(90)90051-H. PMID1962725.
Suman S, Williams E, Thomas P, Surgenor S, Snook J (2003). «Is the risk of adult coeliac disease causally related to cigarette exposure?». Eur J Gastroenterol Hepatol15 (9): 995–1000. doi:10.1097/00042737-200309000-00009. PMID12923372.
van der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE (2010). «Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review». JAMA303 (17): 1738–46. doi:10.1001/jama.2010.549. PMID20442390.
Oberhuber G, Granditsch G, Vogelsang Η (October 1999). «The histopathology of coeliac disease: time for a standardized report scheme for pathologists». Eur J Gastroenterol Hepatol11 (10): 1185–94. doi:10.1097/00042737-199910000-00019. PMID10524652.
Corazza GR, Villanacci V, Zambelli C, et al. (July 2007). «Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease». Clin. Gastroenterol. Hepatol.5 (7): 838–43. doi:10.1016/j.cgh.2007.03.019. PMID17544877.
Akobeng AK, Thomas AG (June 2008). «Systematic review: tolerable amount of gluten for people with coeliac disease». Aliment. Pharmacol. Ther.27 (11): 1044–52. doi:10.1111/j.1365-2036.2008.03669.x. PMID18315587.
Troncone R, Ivarsson A, Szajewska H, Mearin ML (June 2008). «Review article: future research on coeliac disease – a position report from the European multistakeholder platform on coeliac disease (CDEUSSA)». Aliment. Pharmacol. Ther.27 (11): 1030–43. doi:10.1111/j.1365-2036.2008.03668.x. PMID18315588.
Häuser W, Stallmach A, Caspary WF, Stein J (March 2007). «Predictors of reduced health-related quality of life in adults with coeliac disease». Aliment. Pharmacol. Ther.25 (5): 569–78. doi:10.1111/j.1365-2036.2006.03227.x. PMID17305757.
Häuser W, Gold J, Stein J, Caspary WF, Stallmach A (July 2006). «Health-related quality of life in adult coeliac disease in Germany: results of a national survey». Eur J Gastroenterol Hepatol18 (7): 747–54. doi:10.1097/01.meg.0000221855.19201.e8. PMID16772832.
Catassi C, Rätsch I, Gandolfi L, Pratesi R, Fabiani E, El Asmar R, Frijia M, Bearzi I, Vizzoni L (1999). «Why is coeliac disease endemic in the people of the Sahara?». Lancet354 (9179): 647–8. doi:10.1016/S0140-6736(99)02609-4. PMID10466670.
Anderson C, French J, Sammons H, Frazer A, Gerrard J, Smellie J (1952). «Coeliac disease; gastrointestinal studies and the effect of dietary wheat flour». Lancet1 (17): 836–42. doi:10.1016/S0140-6736(52)90795-2. PMID14918439.
Macdonald W, Dobbins W, Rubin C (1965). «Studies of the familial nature of celiac sprue using biopsy of the small intestine». N Engl J Med272 (9): 448–56. doi:10.1056/NEJM196503042720903. PMID14242522.
Section 206 of the Food Allergen Labeling and Consumer Protection Act of 2004, Title II of Pub.L. 108–282, 118 "United States Statutes at Large" 891, enacted August 2, 2004
Cunningham-Rundles C (September 2001). «Physiology of IgA and IgA deficiency». J. Clin. Immunol.21 (5): 303–9. doi:10.1023/A:1012241117984. PMID11720003.
Karell K, Louka AS, Moodie SJ, et al. (2003). «HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease». Hum. Immunol.64 (4): 469–77. doi:10.1016/S0198-8859(03)00027-2. PMID12651074.
Michalski J, McCombs C, Arai T, Elston R, Cao T, McCarthy C, Stevens F (1996). «HLA-DR, DQ genotypes of celiac disease patients and healthy subjects from the West of Ireland». Tissue Antigens47 (2): 127–33. doi:10.1111/j.1399-0039.1996.tb02525.x. PMID8851726.
Kaur G, Sarkar N, Bhatnagar S, et al. (2002). «Pediatric celiac disease in India is associated with multiple DR3-DQ2 haplotypes». Hum. Immunol.63 (8): 677–82. doi:10.1016/S0198-8859(02)00413-5. PMID12121676.
Layrisse Z, Guedez Y, Domínguez E, Paz N, Montagnani S, Matos M, Herrera F, Ogando V, Balbas O, Rodríguez-Larralde A (2001). «Extended HLA haplotypes in a Carib Amerindian population: the Yucpa of the Perija Range». Hum Immunol62 (9): 992–1000. doi:10.1016/S0198-8859(01)00297-X. PMID11543901.
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken E, Schuppan D (1997). «Identification of tissue transglutaminase as the autoantigen of celiac disease». Nat Med3 (7): 797–801. doi:10.1038/nm0797-797. PMID9212111.
Fleckenstein B, Molberg 0, Qiao SW, Schmid DG, Mulbe E von der, Elgstoen K, Jung G and Soflid ML. (2002). «Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process». J Biol Chem277 (37): 34109–34116. doi:10.1074/jbc.M204521200. PMID12093810.
Koning, F.; Schuppan, D.; Cerf-Bensussan, N.; Sollid, M. (June 2005). «"Pathomechanisms in celiac disease"». Best practice & research. Clinical gastroenterology 19. 3, σελ. 373–387. doi:10.1016/j.bpg.2005.02.003. ISSN1521-6918. PMID15925843.
Mowat AM. (2003). «Coeliac disease – a meeting point for genetics, immunology, and protein chemistry». Lancet361 (9365): 1290–1292. doi:10.1016/S0140-6736(03)12989-3. PMID12699968.
Londei M, Ciacci C, Ricciardelli I, Vacca L, Quaratino S, and Maiuri L. (2005). «Gliadin as a stimulator of innate responses in celiac disease». Mol Immunol42 (8): 913–918. doi:10.1016/j.molimm.2004.12.005. PMID15829281.
Salim A, Phillips A, Farthing M (1990). «Pathogenesis of gut virus infection». Baillieres Clin Gastroenterol4 (3): 593–607. doi:10.1016/0950-3528(90)90051-H. PMID1962725.
Suman S, Williams E, Thomas P, Surgenor S, Snook J (2003). «Is the risk of adult coeliac disease causally related to cigarette exposure?». Eur J Gastroenterol Hepatol15 (9): 995–1000. doi:10.1097/00042737-200309000-00009. PMID12923372.
van der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE (2010). «Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review». JAMA303 (17): 1738–46. doi:10.1001/jama.2010.549. PMID20442390.
Wong R, Steele R, Reeves G, Wilson R, Pink A, Adelstein S (2003). «Antibody and genetic testing in coeliac disease». Pathology35 (4): 285–304. PMID12959764.
Oberhuber G, Granditsch G, Vogelsang Η (October 1999). «The histopathology of coeliac disease: time for a standardized report scheme for pathologists». Eur J Gastroenterol Hepatol11 (10): 1185–94. doi:10.1097/00042737-199910000-00019. PMID10524652.
Corazza GR, Villanacci V, Zambelli C, et al. (July 2007). «Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease». Clin. Gastroenterol. Hepatol.5 (7): 838–43. doi:10.1016/j.cgh.2007.03.019. PMID17544877.
Akobeng AK, Thomas AG (June 2008). «Systematic review: tolerable amount of gluten for people with coeliac disease». Aliment. Pharmacol. Ther.27 (11): 1044–52. doi:10.1111/j.1365-2036.2008.03669.x. PMID18315587.
Troncone R, Ivarsson A, Szajewska H, Mearin ML (June 2008). «Review article: future research on coeliac disease – a position report from the European multistakeholder platform on coeliac disease (CDEUSSA)». Aliment. Pharmacol. Ther.27 (11): 1030–43. doi:10.1111/j.1365-2036.2008.03668.x. PMID18315588.
Häuser W, Stallmach A, Caspary WF, Stein J (March 2007). «Predictors of reduced health-related quality of life in adults with coeliac disease». Aliment. Pharmacol. Ther.25 (5): 569–78. doi:10.1111/j.1365-2036.2006.03227.x. PMID17305757.
Häuser W, Gold J, Stein J, Caspary WF, Stallmach A (July 2006). «Health-related quality of life in adult coeliac disease in Germany: results of a national survey». Eur J Gastroenterol Hepatol18 (7): 747–54. doi:10.1097/01.meg.0000221855.19201.e8. PMID16772832.
Catassi C, Rätsch I, Gandolfi L, Pratesi R, Fabiani E, El Asmar R, Frijia M, Bearzi I, Vizzoni L (1999). «Why is coeliac disease endemic in the people of the Sahara?». Lancet354 (9179): 647–8. doi:10.1016/S0140-6736(99)02609-4. PMID10466670.
Anderson C, French J, Sammons H, Frazer A, Gerrard J, Smellie J (1952). «Coeliac disease; gastrointestinal studies and the effect of dietary wheat flour». Lancet1 (17): 836–42. doi:10.1016/S0140-6736(52)90795-2. PMID14918439.
Macdonald W, Dobbins W, Rubin C (1965). «Studies of the familial nature of celiac sprue using biopsy of the small intestine». N Engl J Med272 (9): 448–56. doi:10.1056/NEJM196503042720903. PMID14242522.
Ratzinger, Joseph (24 July 2003). Prot. 89/78-174 98. Congregation for the Doctrine of the Faith. Full text at: «The Use of Mustum and Low-Gluten Hosts at Mass». BCL Newsletter. United States Conference of Catholic Bishops. 2003. Αρχειοθετήθηκε από το πρωτότυπο στις 2 Ιανουαρίου 2007. Ανακτήθηκε στις 7 Μαρτίου 2007.Unknown parameter |month= ignored (βοήθεια)
Ratzinger, Joseph (24 July 2003). Prot. 89/78-174 98. Congregation for the Doctrine of the Faith. Full text at: «The Use of Mustum and Low-Gluten Hosts at Mass». BCL Newsletter. United States Conference of Catholic Bishops. 2003. Αρχειοθετήθηκε από το πρωτότυπο στις 2 Ιανουαρίου 2007. Ανακτήθηκε στις 7 Μαρτίου 2007.Unknown parameter |month= ignored (βοήθεια)